ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Cell

Volumn 92, Issue 6, 1998, Pages 725-734

  Zhang, Yanping ^a   Xiong, Yue ^a   Yarbrough, Wendell G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER; CELL CYCLE; GENE DELETION; GENE LOCUS; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; TUMOR SUPPRESSOR GENE;

EID: 0032549711     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81401-4     Document Type: Article

References (47)

1. Barak, Y., Juven-Gershon, T., Haffner, R., and Oren, M. (1993). Mdm2 expression is induced by wild-type p53 activity. EMBO J. 12, 461-468.
2. Barak, Y., Gottlieb, E., Juven-Gershon, T., and Oren, M. (1994). Regulation of mdm2 expression by p53: alternative promoters produce transcripts with non-identical translation potential. Genes Dev. 8, 1739-1749.
3. Butz, K., Shahabeddin, L., Geisen, C., Spikovsky, D., Ullmann, A., and Hopper-Seyler, F. (1995). Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10, 927-936.
4. Chen, J., Marechal, V., and Levine, A.J. (1993). Mapping of the p53 and mdm-2 interaction domains. Mol. Cell Biol. 13, 4107-4114.
5. Chen, C-Y., Oliner, J.D., Zhan, Q., Fornace, A.J., Vogelstein, B., and Kastan, M. (1994). Interaction between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl. Acad. Sci. USA 91, 2684-2688.
6. Chen, J., Wu, X., Lin, J., and Levine, A.J. (1996). mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell Biol. 16, 2445-2452.
7. Duro, D., Bernard, O., Della Valle, V., Berger, R., and Larsen, C.-J. (1995). A new type of p16INK4a/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 11, 21-29.
8. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J., and Livingston, D.M. (1993). Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487-497.
9. Fields, S., and Song, O. (1989). A novel genetic system to detect protein-protein interactions. Nature 340, 245-246.
10. Gottlieb, M.T., and Oren, M. (1996). p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287, 77-102.
11. Guan, K-L., Jenkins, C.W., Li, Y., Nichols, M.A., Wu, X., O'Keefe, C.L., Matera, A.G., and Xiong, Y. (1994). Growth suppression by p18, a p16INK4/MTS1-and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939-2952.
12. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
13. Huibregtse, J.M., Scheffner, M., and Howley, P.M. (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 13, 4129-4135.
14. Hunter, T., and Pines, J. (1994). Cyclin and cancer II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
15. Jenkins, C.W., and Xiong, Y. (1995). Immunoprecipitation and immunoblotting in cell cycle studies. In Cell Cycle: Material and Methods, M. Pagano, ed. (New York: Springer-Verlag), pp. 250-263.
16. Jones, S.N., Roe, A.E., Donehower, L.A., and Bradley, A. (1995). Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206-208.
17. Kamijo, T., Zindy, F., Roussel, M.F., Quelle, D.E., Downing, J.R., Ashmun, R.A., Grosveld, G., and Sherr, C.J. (1997). Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649-659.
18. Kato, J-y., Matsushime, H., Hiebert, S.W., Ewen, M., and Sherr, C.J. (1993). Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7, 331-342.
19. Ko, L.J., and Prives, C. (1996). p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
20. Kubbutat, M.H.G., Jones, S.N., and Vousden, K.H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
21. Lammie, G.A., and Peters, G. (1991). Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3, 413-420.
22. Leach, F.S., Tokino, P., Meltzer, M., Burrell, J.D., Oliner, S., Smith, D.E., Hill, D., Sidransky, K.W., Kinzler, K., and Vogelstein, B. (1993). p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53, 2231-2234.
23. Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
24. Luna, R.M., Wagner, D.S., and Lozano, G. (1995). Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206.
25. Maki, C.G., Huibregtse, J.M., and Howley, P.M. (1996). In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56, 2649-2654.
26. Mao, L., Merlo, A., Bedi, G., Shapiro, G.I., Edwards, C.D., Rollin, B.J., and Sidransky, D. (1995). A novel p16INK4a transcript. Cancer Res. 55, 2995-2997.
27. Momand, J., Zambetti, G.P., Olson, D.C., George, D., and Levine, A.J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245.
28. Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D.L., and Vogelstein, B. (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358, 80-83.
29. Oliner, J.D., Pietenpol, J.A., Thiagalingam, S., Gyuris, J., Kinzler, K.W., and Vogelstein, B. (1993). Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857-860.
30. Parry, D., Bates, S., Mann, D.J., and Peters, G. (1995). Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumor suppressor gene product. EMBO J. 14, 503-511.
31. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, this issue, 713-723.
32. Quelle, D.E., Zindy, F., Ashmun, R., and Sherr, C.J. (1995). Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000.
33. Quelle, D.E., Cheng, M., Ashmun, R.A., and Sherr, C.J. (1997). Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc. Natl. Acad. Sci. USA 94, 3436-3440.
34. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J., and Howley, P.M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
35. Scheffner, M., Huibregtse, J.M., Vierstra, R.D., and Howley, P.M. (1993). The HPV-16 E6 and E6-AP complex function as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505.
36. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
37. Serrano, M., Lee, H-W., Chin, L., Cordon-Cardos, C., Beach, D., and DePinho, R.A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
38. Sherr, C.J. (1996). Cancer cell cycle. Science 274, 1672-1677.
39. Sherr, C.J., and Roberts, J.M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
40. Shieh, S.-Y., Ikeda, M., Taya, Y., and Prives, C. (1997). DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334.
41. Stone, S., Jiang, P., Dayananth, P., Tavtigian, S.V., Katcher, H., Parry, D., Peters, G., and Kamb, A. (1995). Complex structure and regulation of the p16(MTS1) locus. Cancer Res. 55, 2988-2994.
42. Thut, C.J., Goodrich, J.A., and Tjian, R. (1997). Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Dev. 11, 1974-1986.
43. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
44. Wu, X., Bayle, J.H., Olson, D., and Levine, A.J. (1993). The p53-mdm2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132.
45. Xiong, Y., Zhang, H., and Beach, D. (1993a). Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7, 1527-1583.
46. Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993b). p21 is a universal inhibitor of the cyclin kinases. Nature 366, 701-704.
47. Yarbrough, W.G., Aprelikova, O., Pei, H., Olshan, A.F., Liu, E.T. (1996). Familial tumor syndrome associated with a germline non-functional p16INK4a allele. J. Natl. Cancer Inst. 88, 1489-1491.